ArticleJournal of neuro-oncology

Expression of a soluble transforming growth factor-beta (TGFbeta) receptor reduces tumorigenicity by regulating natural killer (NK) cell activity against 9L gliosarcoma in vivo.

Timothy F Witham et al.PubMed ↗Publisher ↗

No numbers read from the abstract.